Urology Times Innovation Celebration Video Series - Episode 9

Urology Times 50 Innovations Series: Viagra for treatment of erectile dysfunction

EP. 1: Urology Times 50 Innovations Series: PSA testing
EP. 2: Urology Times 50 Innovations Series: Testosterone therapy
EP. 3: Urology Times 50 Innovations Series: Stem cell–derived therapy for stress urinary incontinence
EP. 4: Urology Times 50 Innovations Series: Tissue engineering and regenerative medicine
EP. 5: 50th Anniversary Innovation Celebration: The midurethral sling for stress urinary incontinence
EP. 6: Urology Times 50 Innovations Series: Genetic testing for prostate cancer
EP. 7: Urology Times 50 Innovations Series: Onabotulinumtoxin A for overactive bladder
EP. 8: Urology Times 50 Innovations Series: Clean intermittent catheterization
Now Viewing
EP. 9: Urology Times 50 Innovations Series: Viagra for treatment of erectile dysfunction
EP. 10: Urology Times 50 Innovations Series: Active surveillance for prostate cancer
EP. 11: Urology Times 50 Innovations Series: BCG therapy for bladder cancer
EP. 12: Urology Times 50 Innovations Series: Extracorporeal shock wave lithotripsy for stones
EP. 13: Urology Times 50 Innovations Series: Treatment of female hypoactive sexual desire disorder
EP. 14: Urology Times 50 Innovations Series: Cryotherapy for kidney and prostate cancer
EP. 15: Urology Times 50 Innovations Series: Intralesional therapies for Peyronie's disease
EP. 16: Urology Times 50 Innovations Series: Radiation therapy for prostate cancer
EP. 17: Urology Times 50 Innovations Series: β3 agonists for overactive bladder
EP. 18: Urology Times 50 Innovations Series: Microsurgical testicular sperm extraction
EP. 19: Urology Times 50 Innovations Series: Anatomic radical prostatectomy

As part of the Urology Times' 50th Anniversary Innovation Celebration, Arthur L. Burnett, MD, MBA, FACS, discusses how Viagra has revolutionized sexual dyfunction treatment and management over the past 50 years. Burnett is a Patrick C. Walsh distinguished professor of urology and oncology at the Johns Hopkins University School of Medicine and the James Buchanan Brady Urological Institute in Baltimore, Maryland.